A Coumermycin/Novobiocin-Regulated Gene Expression System

Human Gene Therapy

Volumn 14, Issue 17, 2003, Pages 1619-1629

  Zhao, Hui Fen ^a   Boyd, Jason ^a   Jolicoeur, Normand ^a   Shen, Shi Hsiang ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; COUMAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); NOVOBIOCIN; PROTEIN BAX; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DIMERIZATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAMMAL; MAMMAL CELL; MUTAGENESIS; PROTEIN BINDING; PROTEIN DOMAIN; REPRESSOR GENE;

AMINOCOUMARINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; COUMARINS; DIMERIZATION; DNA GYRASE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; K562 CELLS; LUCIFERASES; LUMINESCENT PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NOVOBIOCIN; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TRANSGENES;

BACTERIA (MICROORGANISMS); EUKARYOTA; MAMMALIA;

EID: 0344010997     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322542266     Document Type: Article

References (30)

1. ALI, J.A., JACKSON, A.P., HOWELLS, A.J., and MAXWELL, A. (1993). The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 32, 2717-2724.
2. BELSHAW, P.J., HO, S.N., CRABTREE, G.R., and SCHREIBER, S.L. (1996). Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl. Acad. Sci. U.S.A. 93, 4604-4607.
3. BOHL, D., NAFFAKH, N., and HEARD, J.M. (1997). Long term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3, 299-305.
4. BYRNE, B.J., DAVIS, M.S., YAMAGUCHI, J., BERGSMA, D.J., and SUBRAMANIAN, K.N. (1983). Definition of the simian virus 40 early promoter region and demonstration of a host range bias in the enhancement effect of the simian virus 40 72-base-pair repeat. Proc. Natl. Acad. Sci. U.S.A. 80, 721-725.
5. CHRAST-BALZ, J., and HOOFT, V.H. (1996). Bi-directional gene switching with the tetracycline repressor and a novel tetracycline antagonist. Nucleic Acids Res. 24, 2900-2904.
6. CHRISTOPHERSON, K.S., MARK, M.R., BAJAJ, V., and GODOWSKI, P.J. (1992). Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc. Natl. Acad. Sci. U.S.A. 89, 6314-6318.
7. DELORT, J.P., and CAPECCHI, M.R. (1996). TAXI/UAS: A molecular switch to control expression of genes in vivo. Hum. Gene Ther. 7, 809-820.
8. EDER, J.P., WHEELER, C.A., TEICHER, B.A., and SCHNIPPER, L.E. (1991). A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. Cancer Res. 51, 510-513.
9. FARRAR, M.A., ALBEROL, I., and PERLMUTTER, R.M. (1996). Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 383, 178-181.
10. FARRAR, M.A., OLSON, S.H., and PERLMUTTER, R.M. (2000). Coumermycin-induced dimerization of GyrB-containing fusion proteins. Methods Enzymol. 327, 421-429.
11. GILBERT, E.J., and MAXWELL, A. (1994). The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs. Mol. Microbiol. 12, 365-373.
12. GODFREY, J.C., and PRICE, K.E. (1972). Structure-activity relationships in coumermycins. Adv. Appl. Microbiol. 15, 231-296.
13. GORMLEY, N.A., ORPHANIDES, G., MEYER, A., CULLIS, P.M., and MAXWELL, A. (1996). The interaction of coumarin antibiotics with fragments of DNA gyrase B protein. Biochemistry 35, 5083-5092.
14. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
15. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
16. GU, J., ZHANG, L., HUANG, X., LIN, T., YIN, M., XU, K., JI, L., ROTH, J.A., and FANG, B. (2002). A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene 21, 4757-4764.
17. HO, S.N., BIGGAR, S.R., SPENCER, D.M., SCHREIBER, S.L., and CRABTREE, G.R. (1996). Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 382, 822-826.
18. HU, J.C., O'SHEA, E.K., KIM, P.S., and SAUER, R.T. (1990). Sequence requirements for coiled-coils: Analysis with λ repressor-GCN4 leucine zipper fusions. Science 250, 1400-1403.
19. JIA, L., PATWARI, Y., SRINIVASULA, S.M., NEWLAND, A.C., FERNANDES-ALNEMRI, T., ALNEMRI, E.S., and KELSEY, S.M. (2001). Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis. Oncogene 20, 4817-4826.
20. KIM, Y.I., and HU, J.C. (1995). Operator binding by λ repressor heterodimers with one or two N-terminal arms. Proc. Natl. Acad. Sci. U.S.A. 92, 7510-7514.
21. KOBAYASHI, T., SAWA, H., MORIKAWA, J., UENO, S., KATAYAMA, N., ZHANG, W., and SHIKU, H. (2002). Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation. Int. J. Oncol. 20, 723-728.
22. NO, D., YAO, T.P., and EVANS, R.M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 3346-3351.
23. O'FARRELL, A.M., LIU, Y., MOORE, K.W., and MUI, A.L. (1998). IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways. EMBO J. 17, 1006-1018.
24. PABO, C.O., SAUER, R.T., STURTEVANT, J.M., and PTASHNE, M. (1979). The λ repressor contains two domains. Proc. Natl. Acad. Sci. U.S.A. 76, 1608-1612.
25. PASTORINO, J.G., CHEN, S.T., TAFANI, M., SNYDER, J.W., and FARBER, J.L. (1998). The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273, 7770-7775.
26. RIVERA, V.M., CLACKSON, T., NATESAN, S., POLLOCK, R., AMARA, J.F., KEENAN, T., MAGARI, S.R., PHILLIPS, T., COURAGE, N.L., CERASOLI, F., JR., HOLT, D.A., and GILMAN, M. (1996). A humanized system for pharmacologic control of gene expression. Nat. Med. 2, 1028-1032.
27. URLINGER, S., BARON, U., THELLMANN, M., HASAN, M.T., BUJARD, H., and HILLEN, W. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U.S.A. 97, 7963-7968.
28. WANG, Y., O'MALLEY, B.W., Jr., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U.S.A. 91, 8180-8184.
29. WANG, Y., DEMAYO, F.J., TSAI, S.Y., and O'MALLEY, B.W. (1997). Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat. Biotechnol. 15, 239-243.
30. WEISS, M.A., PABO, C.O., KARPLUS, M., and SAUER, R.T. (1987). Dimerization of the operator binding domain of phage λ repressor. Biochemistry 26, 897-904.